Get started

Senorespharma

NSE SENORES – Tight Range Signals Breakout SetupSENORES has formed a rounded bottom formation, indicating a shift from a downtrend to an uptrend. After falling from around 876 to 715 , the stock formed a base and then recovered steadily with higher lows, showing gradual buying strength and a healthy trend reversal. Currently, the price is near the 870 – 880 resistance zone and is moving within a tight range, signaling consolidation. A breakout above this level could push the stock higher, while a rejection may trigger a short-term pullback. The overall trend is bullish, but the next move depends on this resistance. We will update with further information soon.
NSE:SENORES
by BrightRally_Research
Nifty is preparing for an upcoming event, stance stays bullish So, the market didn’t move as I expected today. My view was sideways to bullish, but the market clearly turned negative. And that’s the beauty of the market — it has often beaten my 12 years of trading experience and has consistently forced me to learn, adapt, and refine my accuracy. This is exactly why I love the market — it keeps challenging me, and yet, I’ve managed to stay balanced and continue to grow. Now, talking about NSE:NIFTY — today’s volatility was completely expected. Remember, I had mentioned that as we move closer to monthly expiry and with earnings season ongoing, volatility will remain high till the end of this month. For me, Nifty support is at 25000 and resistance at 25150. The overall chart trend is still bullish, but the market seems to be preparing for some upcoming event — and I’m sure many of you already know what that could be. Despite the volatility, my portfolio wasn't affected because we I am strictly trading my Earnings Pivot setups. For example, NSE:SENORES gave a solid 15% move today. But considering market conditions, I booked 80% profit immediately after getting a top-alert. 🎯 In such markets, I will only trade Earnings Pivots. My recent trades also performed strongly today: NSE:OLECTRA – 15.45% UP NSE:FORCEMOT – 11.72% UP That’s all for today. Take care. Have a profitable tomorrow.
NSE:NIFTY
by Trendxinc
1
Senores Pharma cmp 568.20 by Daily Chart view since listed*Senores Pharma cmp 568.20 by Daily Chart view since listed* - Support Zone at 552 to 567 Price Band - Resistance Zone at 555 to 565 Price Band - Falling Resistance Trendline Breakout well sustained - Volumes are in good sync with the avg traded quantity - Rising Support Trendline respected by upside momentum - Back to Back Rounding Bottoms converging into VCP Pattern too - *Support Zone test retested, followed up by Breakout seems to be continuing*
NSE:SENORES
by PIYUSHCHAVDA
Fostering global wellnessSenores Pharmaceuticals Ltd - CMP 526.5 About Incorporated in 2015, Senores Pharmaceuticals Ltd manufactures and develops affordable and high-quality complex generics certified by global food and drugs authorities Key Points Business Overview: SPL is global research driven pharmaceutical company which develops and manufactures pharmaceutical products for the Regulated Markets of US, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Company develops and manufactures specialty, underpenetrated and complex pharmaceutical products. It also manufactures criticalcare injectables and APIs Production Facilities: a) Atlanta Plant: Company manufactures oral solids (tablets and capsules) at its plant in Atlanta, USA, with an installed capacity of Tablets ~132.48 million and Capsules ~38.40 million b) Ahmedabad Plant: Company has 3 units where it manufactures Small Vial Parenterals, Oral Solids & Liquids and Beta Lactum in millions annually. It has a total installed capacity of ~1460 Million c) API: Company manufactures API with an annual installed capacity of ~169 MT Clientele: Prasco LLC, Lannett Company Inc., Jubilant Cadista Pharmaceuticals Inc., Alkem Laboratories, Sun Pharmaceuticals Industries, Dr. Reddy’s Laboratories Inc. and Cipla USA Inc. Overseas Presence: Company has presence in ~43 countries including the Regulated Markets of US, Canada and the United Kingdom Segment Revenue - FY24: Regulated Markets ~68%, Emerging Markets ~21%, Critical Care Injectables ~3%, API ~6%, Other Operational income ~3% IPO: Company has launched its IPO for Fresh issue of shares and Offer for sale and it lists on December 30th 2024 Source: Screener.in This is just to boost my confidence. No Suggestions for buying. I will keep checking and updating my mistake if last post gone wrong... Disclosure: I am not SEBI registered. The information provided here is for educational purposes only. I will not be responsible for any of your profit/loss with these suggestions. Consult your financial Adviser before making any decisions.
NSE:SENORESLong
by Alleyshah
SENORES : Breakout Candidate#SENORES #breakoutsoon #swingtrade #vcppattern #vcpbreakout SENORES : Swing Trade / Momentum trade >> wait for Retracement till black line >> Volumes and Strength Building up >> Beautiful VCP pattern >> Low Risk High Reward Trade Swing Traders can lock profit at 10% and keep Trailing Please Boost, comment and follow us for more Learnings. Note : Markets are still Tricky and can go either ways so don't be over aggressive while choosing & planning your Trades, Calculate your Position sizing as per the Risk Reward you see and most importantly don't go all in Disc : Charts shared are for learning purpose only, not a Trade recommendation. Do your own research and consult your financial advisor before taking any position.
NSE:SENORESLong
by moneyfesttrading